1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global PD-L1 Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 PD-L1 (22C3) 1.2.3 PD-L1(28-8) 1.2.4 PD-L1 (SP142) 1.2.5 PD-L1 (SP263) 1.2.6 Other 1.3 Market by Application 1.3.1 Global PD-L1 Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Diagnostic Center 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global PD-L1 Biomarker Testing Market Perspective (2016-2027) 2.2 PD-L1 Biomarker Testing Growth Trends by Regions 2.2.1 PD-L1 Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 PD-L1 Biomarker Testing Historic Market Share by Regions (2016-2021) 2.2.3 PD-L1 Biomarker Testing Forecasted Market Size by Regions (2022-2027) 2.3 PD-L1 Biomarker Testing Industry Dynamic 2.3.1 PD-L1 Biomarker Testing Market Trends 2.3.2 PD-L1 Biomarker Testing Market Drivers 2.3.3 PD-L1 Biomarker Testing Market Challenges 2.3.4 PD-L1 Biomarker Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top PD-L1 Biomarker Testing Players by Revenue 3.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2016-2021) 3.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2016-2021) 3.2 Global PD-L1 Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue 3.4 Global PD-L1 Biomarker Testing Market Concentration Ratio 3.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2020 3.5 PD-L1 Biomarker Testing Key Players Head office and Area Served 3.6 Key Players PD-L1 Biomarker Testing Product Solution and Service 3.7 Date of Enter into PD-L1 Biomarker Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 PD-L1 Biomarker Testing Breakdown Data by Type 4.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2016-2021) 4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2022-2027) 5 PD-L1 Biomarker Testing Breakdown Data by Application 5.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2016-2021) 5.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America PD-L1 Biomarker Testing Market Size (2016-2027) 6.2 North America PD-L1 Biomarker Testing Market Size by Type 6.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2016-2021) 6.2.2 North America PD-L1 Biomarker Testing Market Size by Type (2022-2027) 6.2.3 North America PD-L1 Biomarker Testing Market Size by Type (2016-2027) 6.3 North America PD-L1 Biomarker Testing Market Size by Application 6.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2016-2021) 6.3.2 North America PD-L1 Biomarker Testing Market Size by Application (2022-2027) 6.3.3 North America PD-L1 Biomarker Testing Market Size by Application (2016-2027) 6.4 North America PD-L1 Biomarker Testing Market Size by Country 6.4.1 North America PD-L1 Biomarker Testing Market Size by Country (2016-2021) 6.4.2 North America PD-L1 Biomarker Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe PD-L1 Biomarker Testing Market Size (2016-2027) 7.2 Europe PD-L1 Biomarker Testing Market Size by Type 7.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2016-2021) 7.2.2 Europe PD-L1 Biomarker Testing Market Size by Type (2022-2027) 7.2.3 Europe PD-L1 Biomarker Testing Market Size by Type (2016-2027) 7.3 Europe PD-L1 Biomarker Testing Market Size by Application 7.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2016-2021) 7.3.2 Europe PD-L1 Biomarker Testing Market Size by Application (2022-2027) 7.3.3 Europe PD-L1 Biomarker Testing Market Size by Application (2016-2027) 7.4 Europe PD-L1 Biomarker Testing Market Size by Country 7.4.1 Europe PD-L1 Biomarker Testing Market Size by Country (2016-2021) 7.4.2 Europe PD-L1 Biomarker Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific PD-L1 Biomarker Testing Market Size (2016-2027) 8.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type 8.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application 8.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region 8.4.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America PD-L1 Biomarker Testing Market Size (2016-2027) 9.2 Latin America PD-L1 Biomarker Testing Market Size by Type 9.2.1 Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2021) 9.2.2 Latin America PD-L1 Biomarker Testing Market Size by Type (2022-2027) 9.2.3 Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2027) 9.3 Latin America PD-L1 Biomarker Testing Market Size by Application 9.3.1 Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2021) 9.3.2 Latin America PD-L1 Biomarker Testing Market Size by Application (2022-2027) 9.3.3 Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2027) 9.4 Latin America PD-L1 Biomarker Testing Market Size by Country 9.4.1 Latin America PD-L1 Biomarker Testing Market Size by Country (2016-2021) 9.4.2 Latin America PD-L1 Biomarker Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa PD-L1 Biomarker Testing Market Size (2016-2027) 10.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type 10.2.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application 10.3.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country 10.4.1 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Agilent Technologies 11.1.1 Agilent Technologies Company Details 11.1.2 Agilent Technologies Business Overview 11.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction 11.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.1.5 Agilent Technologies Recent Development 11.2 Roche 11.2.1 Roche Company Details 11.2.2 Roche Business Overview 11.2.3 Roche PD-L1 Biomarker Testing Introduction 11.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.2.5 Roche Recent Development 11.3 Merck 11.3.1 Merck Company Details 11.3.2 Merck Business Overview 11.3.3 Merck PD-L1 Biomarker Testing Introduction 11.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.3.5 Merck Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction 11.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction 11.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.5.5 AstraZeneca Recent Development 11.6 Ono Pharmaceutical 11.6.1 Ono Pharmaceutical Company Details 11.6.2 Ono Pharmaceutical Business Overview 11.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction 11.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.6.5 Ono Pharmaceutical Recent Development 11.7 Regeneron 11.7.1 Regeneron Company Details 11.7.2 Regeneron Business Overview 11.7.3 Regeneron PD-L1 Biomarker Testing Introduction 11.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.7.5 Regeneron Recent Development 11.8 Innovent 11.8.1 Innovent Company Details 11.8.2 Innovent Business Overview 11.8.3 Innovent PD-L1 Biomarker Testing Introduction 11.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.8.5 Innovent Recent Development 11.9 Hengrui Medicine 11.9.1 Hengrui Medicine Company Details 11.9.2 Hengrui Medicine Business Overview 11.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction 11.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.9.5 Hengrui Medicine Recent Development 11.10 Junshi Biosciences 11.10.1 Junshi Biosciences Company Details 11.10.2 Junshi Biosciences Business Overview 11.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction 11.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2016-2021) 11.10.5 Junshi Biosciences Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of PD-L1 (22C3) Table 3. Key Players of PD-L1(28-8) Table 4. Key Players of PD-L1 (SP142) Table 5. Key Players of PD-L1 (SP263) Table 6. Key Players of Other Table 7. Global PD-L1 Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global PD-L1 Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 9. Global PD-L1 Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million) Table 10. Global PD-L1 Biomarker Testing Market Share by Regions (2016-2021) Table 11. Global PD-L1 Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 12. Global PD-L1 Biomarker Testing Market Share by Regions (2022-2027) Table 13. PD-L1 Biomarker Testing Market Trends Table 14. PD-L1 Biomarker Testing Market Drivers Table 15. PD-L1 Biomarker Testing Market Challenges Table 16. PD-L1 Biomarker Testing Market Restraints Table 17. Global PD-L1 Biomarker Testing Revenue by Players (2016-2021) & (US$ Million) Table 18. Global PD-L1 Biomarker Testing Market Share by Players (2016-2021) Table 19. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-L1 Biomarker Testing as of 2020) Table 20. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2020 Table 21. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2016-2021) Table 22. Key Players Headquarters and Area Served Table 23. Key Players PD-L1 Biomarker Testing Product Solution and Service Table 24. Date of Enter into PD-L1 Biomarker Testing Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 27. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2016-2021) Table 28. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 29. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 30. Global PD-L1 Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 31. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2016-2021) Table 32. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 33. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 34. North America PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 35. North America PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 36. North America PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 37. North America PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 38. North America PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 39. North America PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 40. Europe PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 41. Europe PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 42. Europe PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 43. Europe PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 44. Europe PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 45. Europe PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 46. Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 47. Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 48. Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 49. Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 50. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2016-2021) & (US$ Million) Table 51. Asia-Pacific PD-L1 Biomarker Testing Market Size by Region (2022-2027) & (US$ Million) Table 52. Latin America PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 53. Latin America PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 54. Latin America PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 55. Latin America PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 56. Latin America PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 57. Latin America PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 58. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2016-2021) (US$ Million) Table 59. Middle East & Africa PD-L1 Biomarker Testing Market Size by Type (2022-2027) & (US$ Million) Table 60. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2016-2021) (US$ Million) Table 61. Middle East & Africa PD-L1 Biomarker Testing Market Size by Application (2022-2027) & (US$ Million) Table 62. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2016-2021) & (US$ Million) Table 63. Middle East & Africa PD-L1 Biomarker Testing Market Size by Country (2022-2027) & (US$ Million) Table 64. Agilent Technologies Company Details Table 65. Agilent Technologies Business Overview Table 66. Agilent Technologies PD-L1 Biomarker Testing Product Table 67. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 68. Agilent Technologies Recent Development Table 69. Roche Company Details Table 70. Roche Business Overview Table 71. Roche PD-L1 Biomarker Testing Product Table 72. Roche Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 73. Roche Recent Development Table 74. Merck Company Details Table 75. Merck Business Overview Table 76. Merck PD-L1 Biomarker Testing Product Table 77. Merck Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 78. Merck Recent Development Table 79. Bristol-Myers Squibb Company Details Table 80. Bristol-Myers Squibb Business Overview Table 81. Bristol-Myers Squibb PD-L1 Biomarker Testing Product Table 82. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 83. Bristol-Myers Squibb Recent Development Table 84. AstraZeneca Company Details Table 85. AstraZeneca Business Overview Table 86. AstraZeneca PD-L1 Biomarker Testing Product Table 87. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 88. AstraZeneca Recent Development Table 89. Ono Pharmaceutical Company Details Table 90. Ono Pharmaceutical Business Overview Table 91. Ono Pharmaceutical PD-L1 Biomarker Testing Product Table 92. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 93. Ono Pharmaceutical Recent Development Table 94. Regeneron Company Details Table 95. Regeneron Business Overview Table 96. Regeneron PD-L1 Biomarker Testing Product Table 97. Regeneron Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 98. Regeneron Recent Development Table 99. Innovent Company Details Table 100. Innovent Business Overview Table 101. Innovent Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 102. Innovent Recent Development Table 103. Hengrui Medicine Company Details Table 104. Hengrui Medicine Business Overview Table 105. Hengrui Medicine PD-L1 Biomarker Testing Product Table 106. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 107. Hengrui Medicine Recent Development Table 108. Junshi Biosciences Company Details Table 109. Junshi Biosciences Business Overview Table 110. Junshi Biosciences PD-L1 Biomarker Testing Product Table 111. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2016-2021) & (US$ Million) Table 112. Junshi Biosciences Recent Development Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global PD-L1 Biomarker Testing Market Share by Type: 2020 VS 2027 Figure 2. PD-L1 (22C3) Features Figure 3. PD-L1(28-8) Features Figure 4. PD-L1 (SP142) Features Figure 5. PD-L1 (SP263) Features Figure 6. Other Features Figure 7. Global PD-L1 Biomarker Testing Market Share by Application: 2020 VS 2027 Figure 8. Hospital Case Studies Figure 9. Diagnostic Center Case Studies Figure 10. Others Case Studies Figure 11. PD-L1 Biomarker Testing Report Years Considered Figure 12. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global PD-L1 Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global PD-L1 Biomarker Testing Market Share by Regions: 2020 VS 2027 Figure 15. Global PD-L1 Biomarker Testing Market Share by Regions (2022-2027) Figure 16. Global PD-L1 Biomarker Testing Market Share by Players in 2020 Figure 17. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PD-L1 Biomarker Testing as of 2020 Figure 18. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2020 Figure 19. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2016-2021) Figure 20. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2022-2027) Figure 21. North America PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America PD-L1 Biomarker Testing Market Share by Type (2016-2027) Figure 23. North America PD-L1 Biomarker Testing Market Share by Application (2016-2027) Figure 24. North America PD-L1 Biomarker Testing Market Share by Country (2016-2027) Figure 25. United States PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe PD-L1 Biomarker Testing Market Share by Type (2016-2027) Figure 29. Europe PD-L1 Biomarker Testing Market Share by Application (2016-2027) Figure 30. Europe PD-L1 Biomarker Testing Market Share by Country (2016-2027) Figure 31. Germany PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2016-2027) Figure 39. Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2016-2027) Figure 40. Asia-Pacific PD-L1 Biomarker Testing Market Share by Region (2016-2027) Figure 41. China PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America PD-L1 Biomarker Testing Market Share by Type (2016-2027) Figure 49. Latin America PD-L1 Biomarker Testing Market Share by Application (2016-2027) Figure 50. Latin America PD-L1 Biomarker Testing Market Share by Country (2016-2027) Figure 51. Mexico PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa PD-L1 Biomarker Testing Market Share by Type (2016-2027) Figure 55. Middle East & Africa PD-L1 Biomarker Testing Market Share by Application (2016-2027) Figure 56. Middle East & Africa PD-L1 Biomarker Testing Market Share by Country (2016-2027) Figure 57. Turkey PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE PD-L1 Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 61. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 62. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 64. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 65. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 66. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 67. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 68. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 69. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Agilent Technologies Roche Merck Bristol-Myers Squibb AstraZeneca Ono Pharmaceutical Regeneron Innovent Hengrui Medicine Junshi Biosciences